|

|

Area Editoriale


08/06/2018

Ripetute colonscopie di sorveglianza negative sono predittive di un basso rischio di CCR in pazienti con colite long-standing

Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis

05/05/2018

Rischio di infezioni severe ed opportunistiche in corso di trattamento per malattie infiammatorie intestinali

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases. Kirchgesner J et al. Gastroenterology. 2018 Apr 12. [Epub ahead of print]

24/04/2018

Lo switch ad Infliximab biosimilare è sicuro e ben tollerato in pazienti con IBD in remissione (studio SECURE)

Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trialStrik AS et al.

12/01/2018

Morgensen (GED-0301) è efficace sugli outcome sia clinici che endoscopici a 12 settimane in pazienti con malattia di Crohn in fase attiva

Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's Disease.Feagan BG et al. Gastroenterology. 2018 Jan;154(1):61-64